Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 19, Issue 8, pp. 1708-1718
PubMed
Published By
Print ISSN
Online ISSN
History
- Received January 8, 2020
- Revision received April 8, 2020
- Accepted May 14, 2020
- Published first May 19, 2020.
Article Versions
- Previous version (May 19, 2020 - 05:46).
- Previous version (July 20, 2020 - 08:08).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Jinge Zhao1,
- Shu Ning1,
- Wei Lou1,
- Joy C. Yang1,
- Cameron M. Armstrong1,
- Alan P. Lombard1,
- Leandro S. D'Abronzo1,
- Christopher P. Evans1,2,
- Allen C. Gao1,2,3,*, and
- Chengfei Liu1,2,*
- 1Department of Urologic Surgery, University of California, Davis, Sacramento, California.
- 2UC Davis Comprehensive Cancer Center, University of California, Davis, Sacramento, California.
- 3VA Northern California Health Care System, Sacramento, California.
- ↵*Corresponding Authors:
Chengfei Liu, University of California, Davis, Research 3 Bldg, Suite 1300, 4645 2nd Ave, Sacramento, CA 95817. Phone/Fax: 916-703-5469; E-mail: cffliu{at}ucdavis.edu; and Allen C. Gao, E-mail: acgao{at}ucdavis.edu
August 2020
Volume 19, Issue 8
Volume 19, Issue 8
Cross-Resistance Among Next-Generation Antiandrogen Drugs Through the AKR1C3/AR-V7 Axis in Advanced Prostate Cancer
Jump to section
Advertisement